- Global Multi-centre regitsry study for gall bladder cancer
- Phase 3 multi-centre, international, randomised trial of peri-operative chemotherapy versus adjuvant chemotharpy in patients with locally advanced gall bladder cancer
- Phase-3 multi-centre, international, randomised trial evaluating Bevacizumab as adjuvant therapy following resection of cutaneous melanoma (submitted for ASCO 2009). (Addenbrookes)
- A randomised phase II study comparing Capecitabine plus streptozotocin with or without cisplatin chemotherapy as treatment for unresectable or metastatic neuroendocrine tumours (NET01) (Addenbrookes)